Test Strip Market Report Scope & Overview:

The Test Strip Market size is valued at USD 14.79 Billion in 2025 and is expected to reach USD 22.91 Billion by 2035, growing at a CAGR of 4.74% during the forecast period 2026-2035.

The Test Strip Market analysis report offers detailed insights into the market dynamics, product development, and test applications. The increasing prevalence of diabetes and chronic conditions, the rise of home healthcare and self-test products, the growth of point-of-care testing, and the increasing awareness of rapid infectious disease testing are fuelling the growth of the Test Strip Market during the period 2025-2035.

Test strips used were above 15 billion units in 2025, driven by the increasing prevalence of diabetes, the growth of home healthcare, and the increasing need for multi-diagnostic and rapid test solutions.

Market Size and Forecast:

• Market Size in 2025: USD 14.79 Billion

• Market Size by 2035: USD 22.91 Billion

• CAGR: 4.74% from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

Test Strip Market Trends:

• The prevalence of diabetes and other chronic diseases is on the rise, thereby creating a need for accurate and user-friendly test strips.

• The increased use of home healthcare and self-monitoring products is contributing to the growing use of multi-diagnostic test strips over time.

• The availability of rapid diagnostic tests, home healthcare products, and integrated monitoring products is improving the efficiency and usability of test strips.

• The availability of electrochemical, LFA-based, and biosensor-based technology-enabled test strips is improving usability and efficiency.

• The growing number of hospitals, diagnostic labs, retail pharmacies, and online stores is increasing access to test strips.

• The collaboration of diagnostic companies, healthcare providers, and research institutions is driving innovation, adoption, and accessibility of test strips.

U.S. Test Strip Market Insights:

The US Test Strip Market is expected to grow from a market size of 4.96 billion in 2025 to 7.17 billion in 2035 at a CAGR of 4.01%. The drivers for the market are the increasing incidence of diabetes and other chronic diseases, the rise of home healthcare, the high adoption of multi-diagnostic test strips, and the increasing use of electrochemical, LFA, and biosensors-based test strips in hospitals, diagnostic labs, and retail pharmacies.

Test Strip Market Growth Drivers:

• Increasing incidence of diabetes, chronic, and infectious diseases, which are fuelling the demand for test strips.

The increasing incidence of diabetes, chronic, and infectious diseases is a major factor for the growing Test Strip Market size. The increasing adoption of multi-diagnostic test strips by hospitals, diagnostic labs, retail pharmacies, and home healthcare services for the diagnosis of diabetes, detection of infectious diseases, and management of chronic diseases is a major factor for the increasing Test Strip Market size. The increasing innovations in the design of test strips, including the use of electrochemical, LFA, biosensors, and colorimetric test strips, are also a major factor for the increasing Test Strip Market size.

More than 65% of the hospitals, diagnostic labs, and home healthcare services adopted advanced test strips for the diagnosis of diabetes, detection of infectious diseases, and management of chronic diseases in 2025.

Test Strip Market Restraints:

• High cost of devices and insurance coverage are major factors that restrain the growth of the Test Strip Market in emerging markets.

The high cost of devices is one of the major factors that restrain the growth of the Test Strip Market. Advanced electrochemistry-based, LFA-based, and biosensor-based test strips are costly, thereby restraining the growth of the Test Strip Market in emerging markets. Inconsistent insurance coverage and the high cost of devices are factors that restrain the growth of the Test Strip Market. In addition, the challenges faced in the supply of devices and the lack of professionals to handle the devices are factors that restrain the growth of the Test Strip Market.

Test Strip Market Opportunities:

• Opportunities exist for growth in the Test Strip Market with the increasing usage of integrated, multi-parameter, and digital test strips.

 With the growing need for home healthcare services and the increased usage of home diagnostic tests, the scope for growth in the Test Strip Market is immense. Many hospitals, diagnostic centers, home healthcare providers, and pharmacies are increasingly using integrated and digital test strips to monitor blood glucose levels, diagnose infectious diseases, and monitor other chronic diseases simultaneously. This provides immense opportunities for growth for companies that are developing innovative, accurate, user-friendly, and connected test strips. With the growing need for connected home healthcare services and the increased usage of connected home diagnostic tests, the scope for growth in the Test Strip Market is immense.

In 2025, over 40% of healthcare providers and home users are using advanced multi-diagnostic and connected test strips.

Test Strip Market Segmentation Analysis:

• By Product Type, Blood Glucose Test Strips held the largest market share of 55.25% in 2025, while Infectious Disease Test Strips are expected to grow at the fastest CAGR of 10.54% during 2026–2035.

• By Application, Diabetes Management dominated with a 52.35% market share in 2025, whereas Infectious Disease Diagnosis is projected to record the fastest CAGR of 11.24% through 2026–2035.

• By Technology, Electrochemical Test Strips accounted for the highest market share of 60.35% in 2025, while Lateral Flow Assay (LFA)-based Strips are expected to grow at the fastest CAGR of 9.80% during the forecast period.

• By Distribution Channel, Retail Pharmacies dominated with a 42.27% share in 2025, while Online Pharmacies are anticipated to expand at the fastest CAGR of 13.54% through 2026–2035.

• By End User, Hospitals & Clinics held the largest share of 38.67% in 2025, while Home Care Settings are expected to grow at the fastest CAGR of 12.41% during the forecast period.

By Product Type, Blood Glucose Test Strips Dominate While Infectious Disease Test Strips Grow Rapidly:

The segment of Blood Glucose Test Strips held the largest market size due to the high prevalence of diabetes, clinical acceptance, and home usage. The segment recorded the use of over 8.2 billion units in 2025, showing the high dependence on these test strips in hospitals, clinical labs, and home care settings.

Infectious Disease Test Strips segment is expected to show the highest growth rate due to the increasing awareness of infectious diseases, the need for rapid diagnosis, and the use of test strips for such conditions. The segment recorded the use of over 1.2 billion units in 2025 for conditions such as COVID-19, malaria, and HIV.

By Application, Diabetes Management Leads While Infectious Disease Diagnosis Emerges as Fastest Growing:

Diabetes Management application segment has been dominating the market due to constant monitoring and high usage rate along with its inclusion in digital health platforms. In 2025, over 7.5 billion test strips have been used for glucose monitoring in hospitals, clinics, and home care settings.

Lateral Flow Assay (LFA)-based Strips is witnessing high growth due to quick detection of infectious diseases and high usage in point-of-care testing. Usage has reached over 1.3 billion units in 2025 for quick diagnosis in clinics and remote healthcare settings.

By Technology, Electrochemical Test Strips Have Been Dominating While LFA-Based Strips Witness High Growth:

Electrochemical test strips have dominated the market for years, prized for their precision, consistent results, and easy compatibility with blood glucose monitors. However, lateral flow assay (LFA)-based strips are gaining ground. Demand for blood glucose testing strips is anticipated to exceed 9 billion by 2025.

Lateral Flow Assay (LFA)-based Strips is witnessing high growth due to quick detection of infectious diseases and high usage in point-of-care testing. Usage has reached over 1.3 billion units in 2025 for quick diagnosis in clinics and remote healthcare settings.

By Distribution Channel, Retail Pharmacies Dominate while Online Pharmacies Experience Fast Growth:

The Retail Pharmacies segment has dominated the market as the primary point of purchase for test strips. In 2025, the segment saw more than 4.2 billion units distributed. Their presence and easy access to customers have been significant contributors to the dominance of this segment. In addition, their involvement in chronic disease management programs has further helped them dominate the market. Their relationship with hospitals and home care organizations has also helped them grow.

The Online Pharmacies segment has also grown significantly. This can be attributed to the increase in the number of people using e-commerce services. In addition, the need for home delivery has also contributed to the growth of this segment. In 2025, more than 1.1 billion units were delivered through online pharmacies.

By End User, Hospitals & Clinics Dominate While Home Care Settings Grow Rapidly:

The Hospitals & Clinics segment dominated the market, being the main site for the management of diabetes, chronic conditions, and diagnostic procedures, with over 3.8 billion units used in 2025. The segment has well-established clinical protocols, patient volumes, and integration with EHRs.

The Home Care Settings segment is growing the fastest, driven by the increasing popularity of self-monitoring, telehealth services, and the recognition of the importance of preventive healthcare. The segment used over 1.2 billion test strips in 2025, with the rapid adoption of connected devices and multi-diagnostic solutions for remote patient care.

Test Strip Market Regional Analysis:

North America Test Strip Market Insights:

The North America Test Strip Market holds the highest share in the market, i.e., 38.05% in 2025. This is due to the high prevalence of diabetes and the presence of a well-established healthcare infrastructure in the region. In addition, blood glucose and multi-diagnostic test strips are widely used in hospitals and home care settings. The region also has a high adoption of digital health technologies and chronic disease management programs. The rising need for quick diagnosis of infectious diseases and the increasing adoption of home care monitoring will also boost the North America market. In addition, constant innovation in electrochemical, LFA-based, and biosensor-based test strips will further support the dominance of North America in the already mature market.

U.S. Test Strip Market Insights:

The U.S. Test Strip Market is driven by the high incidence of diabetes, robust home healthcare infrastructure, and extensive adoption of blood glucose, cholesterol, and infectious disease test strips. Growing awareness of self-monitoring, integration with mobile apps, expansion of point-of-care testing, and supportive insurance coverage reinforce the U.S. as the leading market in North America.

Asia-Pacific Test Strip Market Insights:

Asia-Pacific Test Strip Market is growing at a faster pace and is expected to grow at a CAGR of 5.83% during 2025-2035. Factors contributing to this growth include increasing prevalence of diabetes and other lifestyle diseases, increasing demand for point-of-care and home-use test strips, and expansion of healthcare infrastructure in China, India, Japan, and Southeast Asia. High demand for rapid diagnostic and multi-diagnostic test strips, government screening programs, and increasing integration of test strips into telemedicine and hospital infrastructure will boost test strip product adoption and result in rapid market growth in this region.

China Test Strip Market Insights:

China Test Strip Market is driven by increasing prevalence of diabetes and other lifestyle diseases, and increasing demand for test strips for various applications. Factors contributing to this growth include increasing prevalence of diabetes and other lifestyle diseases, increasing demand for test strips for various applications, and expansion of hospital and clinic infrastructure in China.

Europe Test Strip Market Insights:

The Europe Test Strip Market is fueled by the increasing prevalence of diabetes and chronic diseases, the development of healthcare infrastructure, and the increasing use of point-of-care and home-based diagnostics. Countries such as Germany, France, and the UK are major influencers in the Test Strip Market in the European region due to the widespread use of blood glucose, cholesterol, and multi-diagnostic test strips. The development of healthcare infrastructure and the increasing prevalence of chronic diseases are fueling the growth of the Test Strip Market in the European region. The continuous development of electrochemical, LFA, and biosensor technology-based test strips is also fueling the growth of the Test Strip Market in the European region. This further increases the importance of the European region in the Test Strip Market.

Germany Test Strip Market Insights:

The German Test Strip Market is a major contributor to the European Test Strip Market due to the development of healthcare infrastructure and the increasing prevalence of chronic diseases such as diabetes. The German Test Strip Market is fueled by the widespread use of blood glucose, infectious disease, and multi-diagnostic test strips in the country.

Latin America Test Strip Market Insights:

The Latin America Test Strip Market is witnessing growth due to an increase in diabetes and infectious diseases and development in infrastructure. The region is witnessing growth due to an increase in blood glucose, pregnancy, and infectious diseases test strips in Brazil, Mexico, and Argentina. Investments in infrastructure development in hospitals and home care services are boosting the Latin America Test Strip Market. Government screening and awareness campaigns are further boosting the use of test strips.

Middle East & Africa Test Strip Market Insights:

The Middle East & Africa Test Strip Market is witnessing growth due to an increase in diabetes and other chronic diseases and development in infrastructure. The region is witnessing growth due to an increase in blood glucose and infectious diseases test strips and multi-diagnostic test strips in hospitals and home care services. Countries such as Saudi Arabia, UAE, and South Africa are witnessing growth in the Middle East & Africa Test Strip Market. Telemedicine and government campaigns are boosting the use of test strips.

Test Strip Market Competitive Landscape:

Abbott Laboratories is a prominent American healthcare company that has a significant presence in the international Test Strip Market. The company has managed to maintain its position in the market due to its diversified portfolio of diagnostic products and significant investment in research and development. Abbott Laboratories has also managed to maintain its presence in the market due to its presence in the glucose blood strips and its connection to continuous glucose monitoring. The company has also managed to maintain its presence in the market due to its high accuracy in electrochemical strips and its connection to mobile connectivity and telehealth.

• In January 2025, Abbott Laboratories expanded its Freestyle Libre line of products by receiving FDA clearance for new over-the-counter glucose strip configurations.

Roche Holding AG, operating as Roche Diagnostics, is a healthcare leader based in Switzerland, renowned for its Accu-Chek test strip product line, which is used in hospitals, clinics, and home settings for blood glucose and multi-parameter testing applications. Roche is utilizing its high level of experience in the field of diagnostics, and its high level of test strip integration with telehealth solutions, to improve patient results. The high level of manufacturing capabilities and strategic investment in telehealth solutions, enables Roche to hold a commanding lead in the Test Strip Market.

• In May 2025, Roche announced a USD 550 million investment to enhance its Indianapolis-based diagnostics manufacturing site, which will improve the capabilities of CGM and test strip production to support the North American and markets.

Ascensia Diabetes Care Holdings AG is a major independent company that focuses on precision blood glucose test strip chemistry and connectivity products. Ascensia’s Contour Next strips are highly accurate and have strong clinical support, making them highly accepted in hospitals, retail clinics, and home care services. Ascensia’s partnerships and expansion in developing markets give it an edge in terms of its growth path. Ascensia is different from other major companies in terms of its focus on product performance and price.

• In March 2025, Ascensia acquired the distribution rights of Senseonics products related to glucose monitoring. Ascensia also introduced Bluetooth-enabled Contour Advance meters, further integrating itself into digital healthcare platforms.

Test Strip Market Key Players:

Some of the Test Strip Market Companies are: 

• Abbott Laboratories

• Roche Diagnostics

• Ascensia Diabetes Care

• Johnson & Johnson

• Siemens Healthineers

• Nova Biomedical

• Acon Laboratories

• Arkray Inc.

• EKF Diagnostics

• Bayer AG (Diabetes Care Unit)

• Trinity Biotech

• Roche Diabetes Care (Accu-Chek)

• Medtronic plc (Test Strip & CGM Solutions)

• Nipro Corporation

• Omron Healthcare

• Bio-Rad Laboratories

• Terumo Corporation

• Sinocare Inc.

• Lifescan, Inc.

• ForaCare Switzerland AG